At the end of financial year 2022, PT Bio Farma (Persero) generated net sales of approximately ** trillion Indonesian rupiah from its vaccines and serum products. PT Bio Farma (Persero) is a state-owned pharmaceutical enterprise and the leading vaccine manufacturer in Indonesia.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆÆ½â°æ can support your business.
PT Bio Farma (Persero). (June 26, 2023). Net sales of Bio Farma in financial year 2022, by product type (in billion Indonesian rupiah) [Graph]. In ÌÇÐÄÆÆ½â°æ. Retrieved July 29, 2026, from /statistics/1403299/bio-farma-net-sales-by-product/
PT Bio Farma (Persero). "Net sales of Bio Farma in financial year 2022, by product type (in billion Indonesian rupiah)." Chart. June 26, 2023. ÌÇÐÄÆÆ½â°æ. Accessed July 29, 2026. /statistics/1403299/bio-farma-net-sales-by-product/
PT Bio Farma (Persero). (2023). Net sales of Bio Farma in financial year 2022, by product type (in billion Indonesian rupiah). ÌÇÐÄÆÆ½â°æ. ÌÇÐÄÆÆ½â°æ Inc.. Accessed: July 29, 2026. /statistics/1403299/bio-farma-net-sales-by-product/
PT Bio Farma (Persero). "Net Sales of Bio Farma in Financial Year 2022, by Product Type (in Billion Indonesian Rupiah)." ÌÇÐÄÆÆ½â°æ, ÌÇÐÄÆÆ½â°æ Inc., 26 Jun 2023, /statistics/1403299/bio-farma-net-sales-by-product/
PT Bio Farma (Persero), Net sales of Bio Farma in financial year 2022, by product type (in billion Indonesian rupiah) ÌÇÐÄÆÆ½â°æ, /statistics/1403299/bio-farma-net-sales-by-product/ (last visited July 29, 2026)
Net sales of Bio Farma in financial year 2022, by product type (in billion Indonesian rupiah) [Graph], PT Bio Farma (Persero), June 26, 2023. [Online]. Available: /statistics/1403299/bio-farma-net-sales-by-product/